BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 17358084)

  • 1. Diversity-oriented asymmetric synthesis of hapalosin: construction of three small C9/C4/C3-modified hapalosin analogue libraries.
    Dai CF; Cheng F; Xu HC; Ruan YP; Huang PQ
    J Comb Chem; 2007; 9(3):386-94. PubMed ID: 17358084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An efficient approach to trans-4-hydroxy-5-substituted 2-pyrrolidinones through a stereoselective tandem Barbier process: divergent syntheses of (3R,4S)-statines, (+)-preussin and (-)-hapalosin.
    Si CM; Shao LP; Mao ZY; Zhou W; Wei BG
    Org Biomol Chem; 2017 Jan; 15(3):649-661. PubMed ID: 27973631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A practical total synthesis of hapalosin, a 12-membered cyclic depsipeptide with multidrug resistance-reversing activity, by employing improved segment coupling and macrolactonization.
    Palomo C; Oiarbide M; García JM; González A; Pazos R; Odriozola JM; Bañuelos P; Tello M; Linden A
    J Org Chem; 2004 Jun; 69(12):4126-34. PubMed ID: 15176838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Total synthesis and conformational studies of hapalosin, N-desmethylhapalosin and 8-deoxyhapalosin.
    Wagner B; Gonzalez GI; Tran Hun Dau ME; Zhu J
    Bioorg Med Chem; 1999 May; 7(5):737-47. PubMed ID: 10400327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficient synthesis of cryptophycin-52 and novel para-alkoxymethyl unit A analogues.
    Eissler S; Bogner T; Nahrwold M; Sewald N
    Chemistry; 2009 Oct; 15(42):11273-87. PubMed ID: 19760734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combinatorial solid-phase synthesis of hapalosin mimetics.
    Olsen JA; Jensen KJ; Nielsen J
    J Comb Chem; 2000; 2(2):143-50. PubMed ID: 10757094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regioselective conversion of the secondary hydroxyl groups of D-glucuronic acid without the requirement of O-protecting groups.
    Agoston K; Geyer A
    Chemistry; 2005 Oct; 11(21):6407-13. PubMed ID: 16094680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enantioselective synthesis of (+)-cryptophycin 52 (LY355703), a potent antimitotic antitumor agent.
    Ghosh AK; Swanson L
    J Org Chem; 2003 Dec; 68(25):9823-6. PubMed ID: 14656116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis, and evaluation of the multidrug resistance-reversing activity of D-glucose mimetics of hapalosin.
    Dinh TQ; Smith CD; Du X; Armstrong RW
    J Med Chem; 1998 Mar; 41(6):981-7. PubMed ID: 9526572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Asymmetric syntheses and Wnt signal inhibitory activity of melleumin A and four analogues of melleumins A and B.
    Luo JM; Dai CF; Lin SY; Huang PQ
    Chem Asian J; 2009 Feb; 4(2):328-35. PubMed ID: 19072738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Organocatalytic conjugate addition of malonates to alpha,beta-unsaturated aldehydes: asymmetric formal synthesis of (-)-paroxetine, chiral lactams, and lactones.
    Brandau S; Landa A; Franzén J; Marigo M; Jørgensen KA
    Angew Chem Int Ed Engl; 2006 Jun; 45(26):4305-9. PubMed ID: 16646104
    [No Abstract]   [Full Text] [Related]  

  • 12. Synthesis and evaluation of hapalosin and analogs as MDR-reversing agents.
    O'Connell CE; Salvato KA; Meng Z; Littlefield BA; Schwartz CE
    Bioorg Med Chem Lett; 1999 Jun; 9(11):1541-6. PubMed ID: 10386932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and biological activities of hapalosin derivatives with modification at the C12 position.
    Kashihara N; To-e S; Nakamura K; Umezawa K; Yamamura S; Nishiyama S
    Bioorg Med Chem Lett; 2000 Jan; 10(2):101-3. PubMed ID: 10673089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent developments in the use of catalytic asymmetric ammonium enolates in chemical synthesis.
    Gaunt MJ; Johansson CC
    Chem Rev; 2007 Dec; 107(12):5596-605. PubMed ID: 18072805
    [No Abstract]   [Full Text] [Related]  

  • 15. Chiral dialkylaminopyridine catalysts in asymmetric synthesis.
    Wurz RP
    Chem Rev; 2007 Dec; 107(12):5570-95. PubMed ID: 18072804
    [No Abstract]   [Full Text] [Related]  

  • 16. I2-Catalyzed enantioselective ring expansion of beta-lactams to gamma-lactams through a novel C3-C4 bond cleavage. Direct entry to protected 3,4-dihydroxypyrrolidin-2-one derivatives.
    Alcaide B; Almendros P; Cabrero G; Ruiz MP
    Chem Commun (Camb); 2008 Feb; (5):615-7. PubMed ID: 18209807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diversity-oriented synthesis and preliminary biological screening of highly substituted five-membered lactones and lactams originating from an allyboration of aldehydes and imines.
    Elford TG; Ulaczyk-Lesanko A; De Pascale G; Wright GD; Hall DG
    J Comb Chem; 2009; 11(1):155-68. PubMed ID: 19072614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Asymmetric synthesis of 3-amino-delta-lactams and benzo[a]quinolizidines by catalytic cyclization reactions involving azlactones.
    Jiang J; Qing J; Gong LZ
    Chemistry; 2009 Jul; 15(29):7031-4. PubMed ID: 19533693
    [No Abstract]   [Full Text] [Related]  

  • 19. Three new cryptophycins from Nostoc sp. GSV 224.
    Subbaraju GV; Golakoti T; Patterson GM; Moore RE
    J Nat Prod; 1997 Mar; 60(3):302-5. PubMed ID: 9090872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From racemic precursors to fully stereocontrolled products: one-pot synthesis of chiral α-amino lactones and lactams.
    You ZH; Chen YH; Liu YK
    Org Biomol Chem; 2016 Jul; 14(26):6316-27. PubMed ID: 27270561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.